Literature DB >> 8596056

Interference between human herpesvirus 7 and HIV-1 in mononuclear phagocytes.

R W Crowley1, P Secchiero, D Zella, A Cara, R C Gallo, P Lusso.   

Abstract

Human herpesvirus 7 (HHV-7) uses CD4 as a cellular membrane receptor and thereby interferes with infection of CD4+ T cells by HIV-1. We studied the interactions between HHV-7 and a macrophage-tropic HIV-1 isolate (HIV-1BaL) in terminally differentiated human peripheral blood monocyte-derived macrophages, another critical target for infection by HIV-1 in vivo. Exposure of macrophages to HHV-7 alone yielded no signs of virus replication or cytopathic effects. Nevertheless, when macrophages were pre-exposed to either live or UV-inactivated HHV-7 and subsequently infected with HIV-1BaL, a significant dose-dependent inhibition of HIV-1 replication was documented. At day 7 postinfection, the average level of HIV-1 p24 Ag in cultures from five different donors was reduced by 91.7 +/- 8.3% by pretreatment with live HHV-7 and by 91.8 +/- 8.2% by pretreatment with UV-inactivated HHV-7. Moreover, the synthesis of HIV-1 proviral DNA in macrophages pretreated with HHV-7 was completely inhibited during the early stages after infection, suggesting that HHV-7 blocks HIV-1 at the level of interaction with the CD4 receptor. Consistent with this concept, both macrophage and CD4+ T cell cultures with pre-established HIV-1 infection were not susceptible to inhibitory effects of HHV-7. The proliferative response of PBMC to mitogens was only marginally inhibited by exposure to HHV-7 before mitogen stimulation, indicating that the inhibition of HIV-1 infection was not due to a negative effect on cell proliferation. These data demonstrate that HHV-7 is a powerful inhibitor of HIV-1 infection in cells of the mononuclear phagocytic lineage, despite its inability to replicate actively in such cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8596056

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.

Authors:  G Fabio; S N Knight; I M Kidd; S M Noibi; M A Johnson; V C Emery; P D Griffiths; D A Clark
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

2.  CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

Authors:  W Kempf; V Adams; N Wey; R Moos; M Schmid; E Avitabile; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

3.  CXC-chemokine receptor 4 is not a coreceptor for human herpesvirus 7 entry into CD4(+) T cells.

Authors:  Y Zhang; S Hatse; E De Clercq; D Schols
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

4.  Identification and analysis of a lytic-phase origin of DNA replication in human herpesvirus 7.

Authors:  N van Loon; C Dykes; H Deng; G Dominguez; J Nicholas; S Dewhurst
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

5.  Tamplicon-7, a novel T-lymphotropic vector derived from human herpesvirus 7.

Authors:  H Romi; O Singer; D Rapaport; N Frenkel
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

6.  Human herpesvirus 7 infection of lymphoid and myeloid cell lines transduced with an adenovirus vector containing the CD4 gene.

Authors:  M Yasukawa; Y Inoue; H Ohminami; E Sada; K Miyake; T Tohyama; T Shimada; S Fujita
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Productive infection of primary macrophages with human herpesvirus 7.

Authors:  Y Zhang; L de Bolle; S Aquaro; A van Lommel; E De Clercq; D Schols
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor.

Authors:  Kazushi Nakano; Kenjiro Tadagaki; Yuji Isegawa; Mya Mya Aye; Ping Zou; Koichi Yamanishi
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

9.  Prevention of Tumor Formation by Latent Gammaherpesvirus Infection.

Authors:  S Raffegerst; B Steer; M Hohloch; H Adler
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.